Eli Lilly is nearly ready to take another shot at getting approval for a possible Alzheimer’s drug. The drugmaker said Thursday that it plans to submit its potential treatment donanemab…

Read more »

The post Lilly to Seek FDA Approval for Potential Alzheimer’s Drug appeared first on Hamodia.